000153 丰原药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.8678.2298.8058.9007.795
总资产报酬率 ROA (%)2.0753.5393.5953.6223.196
投入资产回报率 ROIC (%)2.9145.0655.2655.2424.651

边际利润分析
销售毛利率 (%)17.50321.76325.70828.22829.748
营业利润率 (%)3.6594.7874.9885.0474.290
息税前利润/营业总收入 (%)4.4005.5475.6295.7995.428
净利润/营业总收入 (%)3.1433.6793.6793.7703.227

收益指标分析
经营活动净收益/利润总额(%)74.05074.50982.30276.54478.096
价值变动净收益/利润总额(%)8.7291.886-0.7357.3276.087
营业外收支净额/利润总额(%)-0.3371.7400.7630.0961.975

偿债能力分析
流动比率 (X)0.9080.8980.9450.8860.964
速动比率 (X)0.6560.6270.6600.5880.627
资产负债率 (%)57.21056.46056.30460.73756.361
带息债务/全部投入资本 (%)32.96431.78427.44836.83929.401
股东权益/带息债务 (%)180.700189.414229.778153.594208.781
股东权益/负债合计 (%)73.93576.12376.41763.67776.136
利息保障倍数 (X)5.8378.2099.3347.7655.163

营运能力分析
应收账款周转天数 (天)87.90972.51462.47260.87266.034
存货周转天数 (天)61.40062.64872.12584.81082.925